Invention Grant
- Patent Title: P21-activated kinase inhibitor domain targeted transgenic mouse
-
Application No.: US15600004Application Date: 2017-05-19
-
Publication No.: US10584353B2Publication Date: 2020-03-10
- Inventor: Jonathan Chernoff , Hoi Yee Chow
- Applicant: Institute For Cancer Research
- Applicant Address: US PA Philadelphia
- Assignee: Institute For Cancer Research
- Current Assignee: Institute For Cancer Research
- Current Assignee Address: US PA Philadelphia
- Agency: Stradley Ronon Stevens & Young, LLP
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C12Q1/6897 ; C12Q1/686 ; A01K67/027
Abstract:
Mice comprising a modified p21-activated kinase (Pak) inhibitor domain (PID*), optionally linked with GST and capable of constitutive expression of PID are provided. Also provided are cells, tissue, and organs obtainable from such mice, and methods for producing mice comprising a modified p21-activated kinase (Pak) inhibitor domain (PID*).
Public/Granted literature
- US20170335342A1 P21-Activated Kinase Inhibitor Domain Targeted Transgenic Mouse Public/Granted day:2017-11-23
Information query
IPC分类:
